MutantDx Technologies
The various patents have been variously combined into processes that are specific for particular clinical applications. They are listed below:
TumorPlex and ASMS
Detection of SNPs from tissue or liquid biopsy samples
PrimaCap
Detecting mutations in small DNA fragments from tissue and liquid biopsy samples
SeqVar
Predicting drug efficacy for treatment with Check Point Inhibitors
RepSeqID and MSI
Detection of deletion/insertion and fusion mutations
Dr Roger Hodkinson
MutantDx Inc.
17204 106A Avenue
Edmonton, Alberta
Canada T5S 1E6
Edmonton, Alberta
Canada T5S 1E6